Non-antibiotic Treatment Modalities for Bacterial Vaginosis


Cite item

Full Text

Abstract

Caused by an imbalance in the vaginal microbiome, bacterial vaginosis (BV) is among the most commonly occurring vaginal infections in women of childbearing age. If untreated, BV may have a detrimental impact on the obstetric and gynecological health of an individual. To date, treatment for BV includes a regimen of antibiotics and avoidance of relevant risk factors. Since recurrence and reinfection are frequently observed in patients, pharmaceutical treatment for BV remains ineffective nevertheless. Repeated exposure to antibiotics could precipitate drug-resistant strains. The severity of this problem leads to the emergence of non-antimicrobial therapies. This article aims to provide a review on the types and efficacy of various alternative, non-antimicrobial therapeutic regimens.

About the authors

Sarah Adelia

Faculty of Medicine, Universitas Airlangg

Email: info@benthamscience.net

Athaya Ardelia

Faculty of Medicine, Universitas Gadjah Mada

Email: info@benthamscience.net

Devi Susetiati

Department of Dermatology and Venereology, Faculty of Medicine Universitas Gadjah Mada

Author for correspondence.
Email: info@benthamscience.net

References

  1. Holmes, K.K.; Sparling, P.; Piot, P.; Wasserheit, J.N.; Wasserheit, J.; Corey, L.; Cohen, M. Sexually Transmitted Diseases, 4th ed; McGraw-Hill Professional, 2008.
  2. Kenyon, C.; Colebunders, R.; Crucitti, T. The global epidemiology of bacterial vaginosis: A systematic review. Am. J. Obstet. Gynecol., 2013, 209(6), 505-523. doi: 10.1016/j.ajog.2013.05.006 PMID: 23659989
  3. Pal, K.; Kumar, N.; Behera, B.; Sagiri, S.S.; Ray, S.; Roy, S. Bacterial vaginosis: Etiology and modalities of treatment-A brief note. J. Pharm. Bioallied Sci., 2011, 3(4), 496-503. doi: 10.4103/0975-7406.90102 PMID: 22219582
  4. Bautista, C.T.; Wurapa, E.; Sateren, W.B.; Morris, S.; Hollingsworth, B.; Sanchez, J.L. Bacterial vaginosis: A synthesis of the literature on etiology, prevalence, risk factors, and relationship with chlamydia and gonorrhea infections. Mil. Med. Res., 2016, 3(1), 4. doi: 10.1186/s40779-016-0074-5 PMID: 26877884
  5. Abou Chacra, L.; Fenollar, F.; Diop, K. Bacterial vaginosis: What do we currently know? Front. Cell. Infect. Microbiol., 2022, 11, 672429. doi: 10.3389/fcimb.2021.672429 PMID: 35118003
  6. Amabebe, E.; Anumba, D.O.C. The vaginal microenvironment: The physiologic role of lactobacilli. Front. Med., 2018, 5, 181. doi: 10.3389/fmed.2018.00181 PMID: 29951482
  7. Muzny, C.A.; Sobel, J.D. The role of antimicrobial resistance in refractory and recurrent bacterial vaginosis and current recommendations for treatment. Antibiotics, 2022, 11(4), 500. doi: 10.3390/antibiotics11040500 PMID: 35453251
  8. Vodstrcil, L.A.; Muzny, C.A.; Plummer, E.L.; Sobel, J.D.; Bradshaw, C.S. Bacterial vaginosis: Drivers of recurrence and challenges and opportunities in partner treatment. BMC Med., 2021, 19(1), 194. doi: 10.1186/s12916-021-02077-3 PMID: 34470644
  9. Chen, X.; Lu, Y.; Chen, T.; Li, R. The female vaginal microbiome in health and bacterial vaginosis. Front. Cell. Infect. Microbiol., 2021, 11, 631972. doi: 10.3389/fcimb.2021.631972 PMID: 33898328
  10. Pekmezovic, M.; Mogavero, S.; Naglik, J.R.; Hube, B. Host–Pathogen Interactions during Female Genital Tract Infections. Trends Microbiol., 2019, 27(12), 982-996. doi: 10.1016/j.tim.2019.07.006 PMID: 31451347
  11. Tachedjian, G.; Aldunate, M.; Bradshaw, C.S.; Cone, R.A. The role of lactic acid production by probiotic Lactobacillus species in vaginal health. Res. Microbiol., 2017, 168(9-10), 782-792. doi: 10.1016/j.resmic.2017.04.001 PMID: 28435139
  12. Joseph, R.J.; Ser, H.L.; Kuai, Y.H.; Tan, L.T.H.; Arasoo, V.J.T.; Letchumanan, V.; Wang, L.; Pusparajah, P.; Goh, B.H.; Ab Mutalib, N.S.; Chan, K.G.; Lee, L.H. Finding a balance in the vaginal microbiome: How do we treat and prevent the occurrence of bacterial vaginosis? Antibiotics, 2021, 10(6), 719. doi: 10.3390/antibiotics10060719 PMID: 34203908
  13. Laue, C.; Papazova, E.; Liesegang, A.; Pannenbeckers, A.; Arendarski, P.; Linnerth, B.; Domig, K.J.; Kneifel, W.; Petricevic, L.; Schrezenmeir, J. Effect of a yoghurt drink containing Lactobacillus strains on bacterial vaginosis in women – a double-blind, randomised, controlled clinical pilot trial. Benef. Microbes, 2018, 9(1), 35-50. doi: 10.3920/BM2017.0018 PMID: 29065710
  14. Wu, S; Hugerth, LW; Schuppe-Koistinen, I; Du, J The right bug in the right place: Opportunities for bacterial vaginosis treatment. NPJ Biofilms Microbiomes., 2022, 8(1) doi: 10.1038/s41522-022-00295-y
  15. Ravel, J.; Gajer, P.; Abdo, Z.; Schneider, G.M.; Koenig, S.S.K.; McCulle, S.L.; Karlebach, S.; Gorle, R.; Russell, J.; Tacket, C.O.; Brotman, R.M.; Davis, C.C.; Ault, K.; Peralta, L.; Forney, L.J. Vaginal microbiome of reproductive-age women. Proc. Natl. Acad. Sci., 2011, 108(S1), 4680-4687. doi: 10.1073/pnas.1002611107 PMID: 20534435
  16. Smith, S.B.; Ravel, J. The vaginal microbiota, host defence and reproductive physiology. J. Physiol., 2017, 595(2), 451-463. doi: 10.1113/JP271694 PMID: 27373840
  17. Ranjit, E.; Raghubanshi, B.R.; Maskey, S.; Parajuli, P. Prevalence of bacterial vaginosis and its association with risk factors among nonpregnant women: A hospital based study. Int. J. Microbiol., 2018, 2018, 1-9. doi: 10.1155/2018/8349601 PMID: 29692813
  18. Javed, A.; Parvaiz, F.; Manzoor, S. Bacterial vaginosis: An insight into the prevalence, alternative treatments regimen and it’s associated resistance patterns. Microb. Pathog., 2019, 127, 21-30. doi: 10.1016/j.micpath.2018.11.046 PMID: 30502515
  19. Brotman, R.M.; Klebanoff, M.A.; Nansel, T.R.; Andrews, W.W.; Schwebke, J.R.; Zhang, J.; Yu, K.F.; Zenilman, J.M.; Scharfstein, D.O. A longitudinal study of vaginal douching and bacterial vaginosis--a marginal structural modeling analysis. Am. J. Epidemiol., 2008, 168(2), 188-196. doi: 10.1093/aje/kwn103 PMID: 18503038
  20. Amsel, R.; Totten, P.A.; Spiegel, C.A.; Chen, K.C.S.; Eschenbach, D.; Holmes, K.K. Nonspecific vaginitis. Am. J. Med., 1983, 74(1), 14-22. doi: 10.1016/0002-9343(83)91112-9 PMID: 6600371
  21. Nugent, R.P.; Krohn, M.A.; Hillier, S.L. Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation. J. Clin. Microbiol., 1991, 29(2), 297-301. doi: 10.1128/jcm.29.2.297-301.1991 PMID: 1706728
  22. Onderdonk, A.B.; Delaney, M.L.; Fichorova, R.N. The human microbiome during bacterial vaginosis. Clin. Microbiol. Rev., 2016, 29(2), 223-238. doi: 10.1128/CMR.00075-15 PMID: 26864580
  23. Menard, J.P. Antibacterial treatment of bacterial vaginosis: current and emerging therapies. Int. J. Womens Health, 2011, 3, 295-305. doi: 10.2147/IJWH.S23814 PMID: 21976983
  24. Tomás, M.; Palmeira-de-Oliveira, A.; Simões, S.; Martinez-de-Oliveira, J.; Palmeira-de-Oliveira, R. Bacterial vaginosis: Standard treatments and alternative strategies. Int. J. Pharm., 2020, 587, 119659. doi: 10.1016/j.ijpharm.2020.119659 PMID: 32687973
  25. Centers for Disease Control and Prevention (CDC). Sexually Transmitted Infections: CDC Treatment Guidelines 2021; U.S. Department of Health and Human Services, 2021.
  26. Chen, R.; Li, R.; Qing, W.; Zhang, Y.; Zhou, Z.; Hou, Y.; Shi, Y.; Zhou, H.; Chen, M. Probiotics are a good choice for the treatment of bacterial vaginosis: A meta-analysis of randomized controlled trial. Reprod. Health, 2022, 19(1), 137. doi: 10.1186/s12978-022-01449-z PMID: 35698149
  27. Mastromarino, P.; Vitali, B.; Mosca, L. Bacterial vaginosis: A review on clinical trials with probiotics. New Microbiol., 2013, 36(3), 229-238. PMID: 23912864
  28. Cribby, S.; Taylor, M.; Reid, G. Vaginal microbiota and the use of probiotics. Interdiscip. Perspect. Infect. Dis., 2008, 2008, 1-9. doi: 10.1155/2008/256490 PMID: 19343185
  29. Han, Y.; Ren, Q. Does probiotics work for bacterial vaginosis and vulvovaginal candidiasis. Curr. Opin. Pharmacol., 2021, 61, 83-90. doi: 10.1016/j.coph.2021.09.004 PMID: 34649216
  30. Reznichenko, H.; Henyk, N.; Maliuk, V.; Khyzhnyak, T.; Tynna, Y.; Filipiuk, I.; Veresniuk, N.; Zubrytska, L.; Quintens, J.; Richir, K.; Gerasymov, S. Oral intake of lactobacilli can be helpful in symptomatic bacterial vaginosis: A randomized clinical study. J. Low. Genit. Tract Dis., 2020, 24(3), 284-289. doi: 10.1097/LGT.0000000000000518 PMID: 32091443
  31. Happel, A.U.; Kullin, B.; Gamieldien, H.; Wentzel, N.; Zauchenberger, C.Z.; Jaspan, H.B.; Dabee, S.; Barnabas, S.L.; Jaumdally, S.Z.; Dietrich, J.; Gray, G.; Bekker, L.G.; Froissart, R.; Passmore, J.A.S. Exploring potential of vaginal Lactobacillus isolates from South African women for enhancing treatment for bacterial vaginosis. PLoS Pathog., 2020, 16(6), e1008559. doi: 10.1371/journal.ppat.1008559 PMID: 32497109
  32. Hidayati, A.N.; Widiatma, R.R.; Murtiastutik, D.; Surono, I.S.; Prakoeswa, C.R.S.; Bintanjoyo, L. Effect of Lactobacillus plantarum IS-10506 supplementation with oral metronidazole for the treatment of bacterial vaginosis: A randomized placebo-controlled clinical trial. J. Pak. Assoc. Dermatol., 2022, 32(4), 707-714.
  33. Vujic, G.; Jajac Knez, A.; Despot Stefanovic, V.; Kuzmic Vrbanovic, V. Efficacy of orally applied probiotic capsules for bacterial vaginosis and other vaginal infections: A double-blind, randomized, placebo-controlled study. Eur. J. Obstet. Gynecol. Reprod. Biol., 2013, 168(1), 75-79. doi: 10.1016/j.ejogrb.2012.12.031 PMID: 23395559
  34. Martinez, R.C.R.; Franceschini, S.A.; Patta, M.C.; Quintana, S.M.; Gomes, B.C.; De Martinis, E.C.P.; Reid, G. Improved cure of bacterial vaginosis with single dose of tinidazole (2 g), Lactobacillus rhamnosus GR-1, and Lactobacillus reuteri RC-14: a randomized, double-blind, placebo-controlled trial. Can. J. Microbiol., 2009, 55(2), 133-138. doi: 10.1139/W08-102 PMID: 19295645
  35. Laughton, J.M.; Devillard, E.; Heinrichs, D.E.; Reid, G.; McCormick, J.K. Inhibition of expression of a staphylococcal superantigen-like protein by a soluble factor from Lactobacillus reuteri. Microbiology, 2006, 152(4), 1155-1167. doi: 10.1099/mic.0.28654-0 PMID: 16549678
  36. Zhang, Y.; Lyu, J.; Ge, L.; Huang, L.; Peng, Z.; Liang, Y.; Zhang, X.; Fan, S. Probiotic Lacticaseibacillus rhamnosus GR-1 and Limosilactobacillus reuteri RC-14 as an adjunctive treatment for bacterial vaginosis do not increase the cure rate in a chinese cohort: A prospective, parallel-group, randomized, controlled study. Front. Cell. Infect. Microbiol., 2021, 11, 669901. doi: 10.3389/fcimb.2021.669901 PMID: 34295831
  37. Balaghi, Z.; Azima, S.; Motamedifar, M.; Kaviani, M.; Poordast, T.; Zare, N. The effect of lactofem oral probiotic capsule on lactobacilli colonization and some vaginal health parameters. Gynecol. Obstet. Invest., 2020, 85(3), 245-251. doi: 10.1159/000506802 PMID: 32252049
  38. Elsharkawy, I.; Noureldin, E.; Mohamed, E.; Mohamed, A.; Abdeldayem, H.; Mansour, S.A.M. Continuous versus interrupted use of vaginal probiotics plus vaginal clindamycin cream for bacterial vaginosis: A randomized controlled study. J. Matern. Fetal Neonatal Med., 2021, 34(1), 58-65. doi: 10.1080/14767058.2019.1588246 PMID: 30879366
  39. Bohbot, J.M.; Daraï, E.; Bretelle, F.; Brami, G.; Daniel, C.; Cardot, J.M. Efficacy and safety of vaginally administered lyophilized Lactobacillus crispatus IP 174178 in the prevention of bacterial vaginosis recurrence. J. Gynecol. Obstet. Hum. Reprod., 2018, 47(2), 81-86. doi: 10.1016/j.jogoh.2017.11.005 PMID: 29196153
  40. Hemalatha, R.; Mastromarino, P.; Ramalaxmi, B.A.; Balakrishna, N.V.; Sesikeran, B. Effectiveness of vaginal tablets containing lactobacilli versus pH tablets on vaginal health and inflammatory cytokines: A randomized, double-blind study. Eur. J. Clin. Microbiol. Infect. Dis., 2012, 31(11), 3097-3105. doi: 10.1007/s10096-012-1671-1 PMID: 22777592
  41. Armstrong, E.; Hemmerling, A.; Miller, S.; Burke, K.E.; Newmann, S.J.; Morris, S.R.; Reno, H.; Huibner, S.; Kulikova, M.; Nagelkerke, N.; Coburn, B.; Cohen, C.R.; Kaul, R. Sustained effect of LACTIN-V (Lactobacillus crispatus CTV-05) on genital immunology following standard bacterial vaginosis treatment: Results from a randomised, placebo-controlled trial. Lancet Microbe, 2022, 3(6), e435-e442. doi: 10.1016/S2666-5247(22)00043-X PMID: 35659905
  42. Ling, Z.; Liu, X.; Chen, W.; Luo, Y.; Yuan, L.; Xia, Y.; Nelson, K.E.; Huang, S.; Zhang, S.; Wang, Y.; Yuan, J.; Li, L.; Xiang, C. The restoration of the vaginal microbiota after treatment for bacterial vaginosis with metronidazole or probiotics. Microb. Ecol., 2013, 65(3), 773-780. doi: 10.1007/s00248-012-0154-3 PMID: 23250116
  43. Abbe, C; Mitchell, CM Bacterial vaginosis: A review of approaches to treatment and prevention. Front Reprod Health., 2023, 5, 1100029. doi: 10.3389/frph.2023.1100029
  44. van Nood, E.; Vrieze, A.; Nieuwdorp, M.; Fuentes, S.; Zoetendal, E.G.; de Vos, W.M.; Visser, C.E.; Kuijper, E.J.; Bartelsman, J.F.W.M.; Tijssen, J.G.P.; Speelman, P.; Dijkgraaf, M.G.W.; Keller, J.J. Duodenal infusion of donor feces for recurrent Clostridium difficile. N. Engl. J. Med., 2013, 368(5), 407-415. doi: 10.1056/NEJMoa1205037 PMID: 23323867
  45. Chen, T.; Xia, C.; Hu, H.; Wang, H.; Tan, B.; Tian, P.; Zhao, X.; Wang, L.; Han, Y.; Deng, K.Y.; Wei, H.; Xin, H.B. Dysbiosis of the rat vagina is efficiently rescued by vaginal microbiota transplantation or probiotic combination. Int. J. Antimicrob. Agents, 2021, 57(3), 106277. doi: 10.1016/j.ijantimicag.2021.106277 PMID: 33434677
  46. Lev-Sagie, A.; Goldman-Wohl, D.; Cohen, Y.; Dori-Bachash, M.; Leshem, A.; Mor, U.; Strahilevitz, J.; Moses, A.E.; Shapiro, H.; Yagel, S.; Elinav, E. Vaginal microbiome transplantation in women with intractable bacterial vaginosis. Nat. Med., 2019, 25(10), 1500-1504. doi: 10.1038/s41591-019-0600-6 PMID: 31591599
  47. Vieira-Baptista, P.; De Seta, F.; Verstraelen, H.; Ventolini, G.; Lonnee-Hoffmann, R.; Lev-Sagie, A. The vaginal microbiome: V. Therapeutic modalities of vaginal microbiome engineering and research challenges. J. Low. Genit. Tract Dis., 2022, 26(1), 99-104. doi: 10.1097/LGT.0000000000000647 PMID: 34928260
  48. Mendling, W.; Shazly, M.A.E.; Zhang, L. The role of lactic acid in the management of bacterial vaginosis: A systematic literature review. Future Pharmacology, 2022, 2(3), 198-213. doi: 10.3390/futurepharmacol2030014
  49. Tyssen, D.; Hearps, A.C.; Guntur, K.; Masson, L.; Cook, S.; Moulton, S.E.; Ravel, J.; Bradshaw, C.S.; Ayehunie, S.; Tachedjian, G. The impact of over-the-counter lactic acid containing vaginal gels on the integrity and inflammatory state of the vaginal epithelium in vitro. Frontiers in Reproductive Health, 2022, 4, 915948. doi: 10.3389/frph.2022.915948 PMID: 36303665
  50. Armstrong-Buisseret, L.; Brittain, C.; Kai, J.; David, M.; Anstey Watkins, J.; Ozolins, M.; Jackson, L.; Abdali, Z.; Hepburn, T.; Griffiths, F.; Montgomery, A.; Daniels, J.; Manley, A.; Dean, G.; Ross, J.D.C. Lactic acid gel versus metronidazole for recurrent bacterial vaginosis in women aged 16 years and over: The VITA RCT. Health Technol. Assess., 2022, 26(2), 1-170. doi: 10.3310/ZZKH4176 PMID: 35057905
  51. Plummer, E.L.; Bradshaw, C.S.; Doyle, M.; Fairley, C.K.; Murray, G.L.; Bateson, D.; Masson, L.; Slifirski, J.; Tachedjian, G.; Vodstrcil, L.A. Lactic acid-containing products for bacterial vaginosis and their impact on the vaginal microbiota: A systematic review. PLoS One, 2021, 16(2), e0246953. doi: 10.1371/journal.pone.0246953 PMID: 33571286
  52. Keller, M.J.; Carpenter, C.A.; Lo, Y.; Einstein, M.H.; Liu, C.; Fredricks, D.N.; Herold, B.C. Phase I randomized safety study of twice daily dosing of acidform vaginal gel: candidate antimicrobial contraceptive. PLoS One, 2012, 7(10), e46901. doi: 10.1371/journal.pone.0046901 PMID: 23056520
  53. van der Veer, C.; Bruisten, S.M.; van Houdt, R.; Matser, A.A.; Tachedjian, G.; van de Wijgert, J.H.H.M.; de Vries, H.J.C.; van der Helm, J.J. Effects of an over-the-counter lactic-acid containing intra-vaginal douching product on the vaginal microbiota. BMC Microbiol., 2019, 19(1), 168. doi: 10.1186/s12866-019-1545-0 PMID: 31345159
  54. O’Hanlon, D.E.; Moench, T.R.; Cone, R.A. In vaginal fluid, bacteria associated with bacterial vaginosis can be suppressed with lactic acid but not hydrogen peroxide. BMC Infect. Dis., 2011, 11(1), 200. doi: 10.1186/1471-2334-11-200 PMID: 21771337
  55. Khazaeian, S.; Navidian, A.; Navabi-Rigi, S.; Araban, M.; Mojab, F.; Khazaeian, S. Comparing the effect of sucrose gel and metronidazole gel in treatment of clinical symptoms of bacterial vaginosis: A randomized controlled trial. Trials, 2018, 19(1), 585. doi: 10.1186/s13063-018-2905-z PMID: 30367673
  56. Xiao, B.B.; Zhang, D.; Chen, R.; Shi, H.R.; Xin, X.R.; Wang, H.L.; Pang, Y.C.; Zhu, S.N.; Yao, C.; Liao, Q.P. Sucrose gel for treatment of bacterial vaginosis: A randomized, double-blind, multi-center, parallel-group, phase III clinical trial. Beijing Da Xue Xue Bao, 2015, 47(6), 925-932. PMID: 26679652
  57. Hu, K.; Zheng, J.; Yu, Z.; Chen, Z.; Cheng, H.; Pan, W.; Yang, W.; Wang, H.; Deng, Q.; Zeng, Z. Directed shift of vaginal microbiota induced by vaginal application of sucrose gel in rhesus macaques. Int. J. Infect. Dis., 2015, 33, 32-36. doi: 10.1016/j.ijid.2014.12.040 PMID: 25546169
  58. Tominaga, K.; Sato, S.; Hayashi, M. Activated charcoal as an effective treatment for bacterial vaginosis. Pers. med. universe., 2012, 1(1), 54-57. doi: 10.1016/j.pmu.2012.05.009
  59. Kopel, J.; McDonald, J.; Hamood, A. An assessment of the in vitro models and clinical trials related to the antimicrobial activities of phytochemicals. Antibiotics, 2022, 11(12), 1838. doi: 10.3390/antibiotics11121838 PMID: 36551494
  60. Murina, F.; Vicariotto, F.; Di Francesco, S. Thymol, eugenol and lactobacilli in a medical device for the treatment of bacterial vaginosis and vulvovaginal candidiasis. New Microbiol., 2018, 41(3), 220-224. PMID: 29874389
  61. Abedi, P.; Pazhohideh, Z.; Mohammadi, S.; Bahrami, N.; Mojab, F.; Maraghi, E. The effect of Calendula officinalisversus metronidazole on bacterial vaginosis in women: A double-blind randomized controlled trial. J. Adv. Pharm. Technol. Res., 2018, 9(1), 15-19. doi: 10.4103/japtr.JAPTR_305_17 PMID: 29441319
  62. Afzali, E.; siahposh, A.; Haghighi-Zadeh, M.H.; Farajzadeh, A.; Abbaspoor, Z. The effect of Quercus (Oak Gal) vaginal cream versus metronidazole vaginal gel on bacterial vaginosis: A double-blind randomized controlled trial. Complement. Ther. Med., 2020, 52, 102497. doi: 10.1016/j.ctim.2020.102497 PMID: 32951746
  63. Askari, S.F.; Jahromi, B.N.; Dehghanian, A.; Zarei, A.; Tansaz, M.; Badr, P.; Azadi, A.; Mohagheghzadeh, A. Effect of a novel herbal vaginal suppository containing myrtle and oak gall in the treatment of vaginitis: A randomized clinical trial. Daru, 2020, 28(2), 603-614. doi: 10.1007/s40199-020-00365-6 PMID: 32888185
  64. Abu-Zaid, A.; Alshahrani, M.S.; Bakhsh, H.; Miski, N.T.; Abuzaid, M.; Alomar, O.; Jabrah, E.; Jamjoom, M.Z.; Salem, H.; Al-Badawi, I.A.; Baradwan, S. Astodrimer gel for treatment of bacterial vaginosis: A systematic review and meta-analysis of randomized controlled trials. Int. J. Clin. Pract., 2021, 75(7), e14165. doi: 10.1111/ijcp.14165 PMID: 33749959
  65. Mendling, W.; Holzgreve, W. Astodrimer sodium and bacterial vaginosis: A mini review. Arch. Gynecol. Obstet., 2022, 306(1), 101-108. doi: 10.1007/s00404-022-06429-z PMID: 35246717
  66. Chavoustie, S.E.; Carter, B.A.; Waldbaum, A.S.; Donders, G.G.G.; Peters, K.H.; Schwebke, J.R.; Paull, J.R.A.; Price, C.F.; Castellarnau, A.; McCloud, P.; Kinghorn, G.R. Two phase 3, double-blind, placebo-controlled studies of the efficacy and safety of Astodrimer 1% Gel for the treatment of bacterial vaginosis. Eur. J. Obstet. Gynecol. Reprod. Biol., 2020, 245, 13-18. doi: 10.1016/j.ejogrb.2019.11.032 PMID: 31812702
  67. Waldbaum, A.S.; Schwebke, J.R.; Paull, J.R.A.; Price, C.F.; Edmondson, S.R.; Castellarnau, A.; McCloud, P.; Kinghorn, G.R. A phase 2, double-blind, multicenter, randomized, placebo-controlled, dose-ranging study of the efficacy and safety of Astodrimer Gel for the treatment of bacterial vaginosis. PLoS One, 2020, 15(5), e0232394. doi: 10.1371/journal.pone.0232394 PMID: 32365097
  68. Schwebke, J.R.; Carter, B.A.; Waldbaum, A.S.; Agnew, K.J.; Paull, J.R.A.; Price, C.F.; Castellarnau, A.; McCloud, P.; Kinghorn, G.R. A phase 3, randomized, controlled trial of Astodrimer 1% Gel for preventing recurrent bacterial vaginosis. Eur. J. Obstet. Gynecol. Reprod. Biol. X, 2021, 10, 100121. doi: 10.1016/j.eurox.2021.100121 PMID: 33537666
  69. Mendling, W.; Weissenbacher, E.R.; Gerber, S.; Prasauskas, V.; Grob, P. Use of locally delivered dequalinium chloride in the treatment of vaginal infections: a review. Arch. Gynecol. Obstet., 2016, 293(3), 469-484. doi: 10.1007/s00404-015-3914-8 PMID: 26506926
  70. Casa, V.; Noll, H.; Gonser, S.; Grob, P.; Graf, F.; Pohlig, G. Antimicrobial activity of dequalinium chloride against leading germs of vaginal infections. Arzneimittelforschung, 2011, 52(9), 699-705. doi: 10.1055/s-0031-1299954 PMID: 12404886
  71. Petersen, E.; Weissenbacher, E.; Hengst, P.; Spitzbart, H.; Wolfgang, W.; Wolff, F.; Dreher, E.; Ernst, U.; Casa, V.; Pohlig, G.; Graf, F.; Kaiser, R. Local treatment of vaginal infections of varying etiology with dequalinium chloride or povidone iodine. A randomised, double-blind, active-controlled, multicentric clinical study. Arzneimittelforschung, 2011, 52(9), 706-715. doi: 10.1055/s-0031-1299955 PMID: 12404887
  72. Gaspar, C.; Rolo, J.; Cerca, N.; Palmeira-de-Oliveira, R.; Martinez-de-Oliveira, J.; Palmeira-de-Oliveira, A. Dequalinium chloride effectively disrupts bacterial vaginosis (BV) Gardnerella spp. Biofilms. Pathogens, 2021, 10(3), 261. doi: 10.3390/pathogens10030261 PMID: 33668706
  73. Weissenbacher, E.R.; Donders, G.; Unzeitig, V.; Martinez de Tejada, B.; Gerber, S.; Halaška, M.; Špaček, J. A comparison of dequalinium chloride vaginal tablets (Fluomizin®) and clindamycin vaginal cream in the treatment of bacterial vaginosis: a single-blind, randomized clinical trial of efficacy and safety. Gynecol. Obstet. Invest., 2012, 73(1), 8-15. doi: 10.1159/000332398 PMID: 22205034
  74. Antoni Vives, J.; Cancelo, M.J.; Losada, M.Á.; Doménech, A. Dequalinium chloride use in adult Spanish women with bacterial vaginosis: An observational study. J. Obstet. Gynaecol., 2022, 42(1), 103-109. doi: 10.1080/01443615.2020.1867966 PMID: 33629634
  75. Surapaneni, S.; Akins, R.; Sobel, J.D. Recurrent bacterial vaginosis: An unmet therapeutic challenge. experience with a combination pharmacotherapy long-term suppressive regimen. Sex. Transm. Dis., 2021, 48(10), 761-765. doi: 10.1097/OLQ.0000000000001420 PMID: 34110746
  76. Reichman, O.; Akins, R.; Sobel, J.D. Boric acid addition to suppressive antimicrobial therapy for recurrent bacterial vaginosis. Sex. Transm. Dis., 2009, 36(11), 732-734. doi: 10.1097/OLQ.0b013e3181b08456 PMID: 19704395
  77. Marrazzo, J.M.; Dombrowski, J.C.; Wierzbicki, M.R.; Perlowski, C.; Pontius, A.; Dithmer, D.; Schwebke, J. Safety and efficacy of a novel vaginal anti-infective, TOL-463, in the treatment of bacterial vaginosis and vulvovaginal candidiasis: A randomized, single-blind, phase 2, controlled trial. Clin. Infect. Dis., 2019, 68(5), 803-809. doi: 10.1093/cid/ciy554 PMID: 30184181

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2024 Bentham Science Publishers